Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Nov 15, 2013 (Vol. 33, No. 20)

Malaria Atlas Project (MAP)

URL:www.map.ox.ac.uk
  • Good use of maps, well organized
  • Nothing major

The Malaria Atlas Project (MAP) provides a great deal of educational information about malaria, and this information includes (appropriately enough) a number of maps. Information on the site is organized in a geographic-centric manner, with site visitors able to browse information by country or geographic region. The website includes content related to the disease itself, the mosquito vectors that transmit malaria, and measures to control the spread of malaria, among other topics. The site is well organized and has a nice design aesthetic, allowing easy browsing of the website’s content. A particularly useful feature for epidemiologists, physicians, and other researchers is the publications page, which provides citations for all of the primary literature that is referenced on the website. The maps themselves are both graphically interesting and informative, providing variety in how information is presented to site visitors.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »